Author Correction: A novel antibiotic class targeting the lipopolysaccharide transporter.

Saved in:
Bibliographic Details
Title: Author Correction: A novel antibiotic class targeting the lipopolysaccharide transporter.
Authors: Zampaloni C; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Mattei P; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Bleicher K; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; SixPeaks Bio, Basel, Switzerland., Winther L; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Thäte C; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; Preclinical Sciences and Translational Safety, Janssen Pharmaceutica, Beerse, Belgium., Bucher C; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Adam JM; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; AutoChem R&D, Mettler-Toledo International, Greifensee, Switzerland., Alanine A; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; Independent consultant, Cambridge, Great Britain., Amrein KE; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Baidin V; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA., Bieniossek C; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Bissantz C; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Boess F; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Cantrill C; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Clairfeuille T; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Dey F; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Di Giorgio P; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., du Castel P; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Dylus D; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Dzygiel P; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Felici A; Discovery Microbiology, Aptuit (Verona) Srl, an Evotec Company, Verona, Italy., García-Alcalde F; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Haldimann A; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Leipner M; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Leyn S; Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA., Louvel S; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Misson P; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Osterman A; Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA., Pahil K; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA., Rigo S; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Schäublin A; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; SixPeaks Bio, Basel, Switzerland., Scharf S; Roche Pharma Research and Early Development, Informatics, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Schmitz P; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Stoll T; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Trauner A; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Zoffmann S; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; Therapeutics Discovery, Janssen Pharmaceutica, Beerse, Belgium., Kahne D; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA., Young JAT; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Lobritz MA; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland. michael.lobritz@roche.com., Bradley KA; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland. kenneth.bradley@roche.com.
Source: Nature [Nature] 2024 Jul; Vol. 631 (8022), pp. E17.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38992182
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: A novel antibiotic class targeting the lipopolysaccharide transporter.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zampaloni+C%22">Zampaloni C</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mattei+P%22">Mattei P</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bleicher+K%22">Bleicher K</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; SixPeaks Bio, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Winther+L%22">Winther L</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Thäte+C%22">Thäte C</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; Preclinical Sciences and Translational Safety, Janssen Pharmaceutica, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Bucher+C%22">Bucher C</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Adam+JM%22">Adam JM</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; AutoChem R&D, Mettler-Toledo International, Greifensee, Switzerland.<br /><searchLink fieldCode="AU" term="%22Alanine+A%22">Alanine A</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; Independent consultant, Cambridge, Great Britain.<br /><searchLink fieldCode="AU" term="%22Amrein+KE%22">Amrein KE</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Baidin+V%22">Baidin V</searchLink>; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bieniossek+C%22">Bieniossek C</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bissantz+C%22">Bissantz C</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Boess+F%22">Boess F</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cantrill+C%22">Cantrill C</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Clairfeuille+T%22">Clairfeuille T</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dey+F%22">Dey F</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Di+Giorgio+P%22">Di Giorgio P</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22du+Castel+P%22">du Castel P</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dylus+D%22">Dylus D</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dzygiel+P%22">Dzygiel P</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Felici+A%22">Felici A</searchLink>; Discovery Microbiology, Aptuit (Verona) Srl, an Evotec Company, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22García-Alcalde+F%22">García-Alcalde F</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Haldimann+A%22">Haldimann A</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Leipner+M%22">Leipner M</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Leyn+S%22">Leyn S</searchLink>; Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Louvel+S%22">Louvel S</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Misson+P%22">Misson P</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Osterman+A%22">Osterman A</searchLink>; Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pahil+K%22">Pahil K</searchLink>; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rigo+S%22">Rigo S</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schäublin+A%22">Schäublin A</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; SixPeaks Bio, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Scharf+S%22">Scharf S</searchLink>; Roche Pharma Research and Early Development, Informatics, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schmitz+P%22">Schmitz P</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Stoll+T%22">Stoll T</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Trauner+A%22">Trauner A</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Zoffmann+S%22">Zoffmann S</searchLink>; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.; Therapeutics Discovery, Janssen Pharmaceutica, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Kahne+D%22">Kahne D</searchLink>; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Young+JAT%22">Young JAT</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lobritz+MA%22">Lobritz MA</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland. michael.lobritz@roche.com.<br /><searchLink fieldCode="AU" term="%22Bradley+KA%22">Bradley KA</searchLink>; Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland. kenneth.bradley@roche.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220410462%22">Nature</searchLink> [Nature] 2024 Jul; Vol. 631 (8022), pp. E17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0410462 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4687 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200280836%22">00280836 </searchLink><i>NLM ISO Abbreviation: </i>Nature <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38992182
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41586-024-07641-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: E17
    Titles:
      – TitleFull: Author Correction: A novel antibiotic class targeting the lipopolysaccharide transporter.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zampaloni C
      – PersonEntity:
          Name:
            NameFull: Mattei P
      – PersonEntity:
          Name:
            NameFull: Bleicher K
      – PersonEntity:
          Name:
            NameFull: Winther L
      – PersonEntity:
          Name:
            NameFull: Thäte C
      – PersonEntity:
          Name:
            NameFull: Bucher C
      – PersonEntity:
          Name:
            NameFull: Adam JM
      – PersonEntity:
          Name:
            NameFull: Alanine A
      – PersonEntity:
          Name:
            NameFull: Amrein KE
      – PersonEntity:
          Name:
            NameFull: Baidin V
      – PersonEntity:
          Name:
            NameFull: Bieniossek C
      – PersonEntity:
          Name:
            NameFull: Bissantz C
      – PersonEntity:
          Name:
            NameFull: Boess F
      – PersonEntity:
          Name:
            NameFull: Cantrill C
      – PersonEntity:
          Name:
            NameFull: Clairfeuille T
      – PersonEntity:
          Name:
            NameFull: Dey F
      – PersonEntity:
          Name:
            NameFull: Di Giorgio P
      – PersonEntity:
          Name:
            NameFull: du Castel P
      – PersonEntity:
          Name:
            NameFull: Dylus D
      – PersonEntity:
          Name:
            NameFull: Dzygiel P
      – PersonEntity:
          Name:
            NameFull: Felici A
      – PersonEntity:
          Name:
            NameFull: García-Alcalde F
      – PersonEntity:
          Name:
            NameFull: Haldimann A
      – PersonEntity:
          Name:
            NameFull: Leipner M
      – PersonEntity:
          Name:
            NameFull: Leyn S
      – PersonEntity:
          Name:
            NameFull: Louvel S
      – PersonEntity:
          Name:
            NameFull: Misson P
      – PersonEntity:
          Name:
            NameFull: Osterman A
      – PersonEntity:
          Name:
            NameFull: Pahil K
      – PersonEntity:
          Name:
            NameFull: Rigo S
      – PersonEntity:
          Name:
            NameFull: Schäublin A
      – PersonEntity:
          Name:
            NameFull: Scharf S
      – PersonEntity:
          Name:
            NameFull: Schmitz P
      – PersonEntity:
          Name:
            NameFull: Stoll T
      – PersonEntity:
          Name:
            NameFull: Trauner A
      – PersonEntity:
          Name:
            NameFull: Zoffmann S
      – PersonEntity:
          Name:
            NameFull: Kahne D
      – PersonEntity:
          Name:
            NameFull: Young JAT
      – PersonEntity:
          Name:
            NameFull: Lobritz MA
      – PersonEntity:
          Name:
            NameFull: Bradley KA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2024 Jul
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1476-4687
          Numbering:
            – Type: volume
              Value: 631
            – Type: issue
              Value: 8022
          Titles:
            – TitleFull: Nature
              Type: main
ResultId 1